fbpx

Clinical Trials

A clinical trial is a research study to determine whether a specific medicine, treatment or device is safe and effective for humans. For more information about clinical trials and the clinical trial process please see the Clinical Trials section

How to search for a clinical trial in your area?

Speak to your physician about any available clinical trials in your area.

Another good resource is http://www.clinicaltrials.gov. Simply enter your condition, click on "maps" and review the trials that are still accepting patients.

Pros & Cons of clinical trials?

For more information about the pros and cons of clinical trials read this brochure from our partner the Canadian Skin Patient Alliance 

canstockphoto1190758There are many different treatments available for psoriasis patients.  What works for one patient, may not work for the other, even if there symptoms are very similar. 

The three main classes of treatment are called:

topicals,

systemics, and

biologics.

Patient Support Programs (PSPs) for People Taking Biologics/Biosimilars

Overview of PSP Services for Psoriasis & Psoriatic Arthritis

Below you will find a listing of all Patient Support Programs for all the biologics and biosimilars currently being used to treat psoriatic disease. The information outlines the drug, how it is administered, who is the associated pharmaceutical company along with details on the Patient Support Program associated with that medication. The information outlines the support that is offered for patients currently taking that medication.

Psoriatic Arthritis

Name of
Treatment
Administration Pharmaceutical
Company
Name
of PSP
Cimzia Injection UCB Canada CIMZIASolutions
Cosentyx Injection Novartis XPOSE
Erelzi Injection

Sandoz
(a division of Novartis)

XPOSE
Enbrel Injection Amgen Enliven Services
Humira Injection AbbVie AbbvieCare
Orencia Injection Bristol-Myers-Squibb Response

Inflectra
(biosimilar to Remicade)

IV Infusion Pfizer Inflectra Patient Support Program

Renflexis
(biosimilar to Remicade)

IV Infusion Merck Harmony
Remicade IV Infusion Janssen BioAdvance
Simponi IV Infusion Janssen BioAdvance
Simponi Aria IV Infusion Janssen BioAdvance
Stelara Injection Janssen BioAdvance
Taltz Injection Eli Lilly Canada Inc LillyPlus TM
For Psoriasis
Name of Treatment Administration Pharmaceutical Company Name of PSP
Cimzia Injection UCB Canada CIMZIA Solutions
Cosentyx Injection Novartis XPOSE
Erelzi Injection

Sandoz
(a division of Novartis)

XPOSE
Enbrel Injection Amgen Enliven Services
Humira Injection AbbVie AbbvieCare
Skyrizi Injection AbbVie AbbvieCare

Inflectra
(biosimilar to Remicade)

IV Infusion Pfizer Inflectra Patient Support Program

Renflexis
(biosimilar to Remicade)

IV Infusion Merck Harmony
Siliq Injection Bausch Health Siliq Patient Support Program
Remicade IV Infusion Janssen BioAdvance
Stelara Injection Janssen BioAdvance
Tremfya Injection Janssen BioAdvance
Taltz Injection Eli Lilly Canada Inc LillyPlus TM

Patient Support Programs

You may qualify for a Patient Support Program offered by the manufacturer of the medication which can offer support to access the drug you require. In some cases, reimbursement assistance is available. In some cases, your physician's office may have to coordinate with the Patient Support Program whereas in others you the patient can reach out directly. Contact manufacturer for details.

 

Medication

Manufacturer

Contact

Cosentyx

(Sekukinumab)

Novartis

Cosentyx™ Connect (Patient Support Program)

Cosentyx™ Connect Personal Support Program ™.
1-844-267-3689

Enbrel

(Etanercept)

Amgen

Enbrel®

Enliven Services:

1-877-9ENBREL

1-877-936-2735

Humira

(Adalimumab)

 

Abbvie

1-866-848-6472

https://www.abbviecare.ca/humira/userenbre

Otezla

(Apremilast Tablets)

Celgene

PrOtezla® ez Start

1-844-ez-Start

1-844-397-8278

Remicade (Influximab),

Simponi (golimumab),

Stelara (ustekinumab)

Janssen

1-866-872-5770

https://www.bioadvancemember.ca/login.aspx

  Janssen

Biolgoics Savings Partnership

https://www.biologicsavingspartnership.com

Silkis

Galderma

905-762-2472

Taltz

Ixekizumab

Eli Lilly

1-888-545-5972

 

Patient Support Preferences

CAPP asked patients who are using or have used a Patient Support Program what aspects of the program they valued the most. These programs offer different services (see the tables above), including help getting insurance coverage, financial assistance and support in using the drug. Overall, the services provided by PSPs that help patients access the biologic / biosimilar that they have been prescribed were the most highly valued by patients.

Do you have an experience you’d like to share? Let us know at .

Click the image to read the report:

PSP report cover

 

Each province or territory covers medication differently. The following table details which medications are covered and the qualifications for public coverage. Access to standard care drugs depends on where patients live.You'll see that some are considered "Special Access" or "Restricted Access" which means they usually require you to have tried ( and 'failed' ) other therapies first and require your doctor to send some forms in to the Ministry of Health or to the Health Authority for approval. In this case, your dermatologist may require access to your medical records.

Table: Funding status by province of medications to treat psoriasis and psoriatic arthritis
Abbreviations: SA = Special Authorization (aka "limited use" or "exceptional drug status")
NIHB = Non-Insured Health Benefits. Covers registered First Nations and Inuit. Used by NT and NU.

 

Psoriasis 

psoriasis drugs

 

Psoriatic Arthritis

psa drugs

 

Special Authorization Chart per province

Each province and territory has a different hurdle that patients must reach in order to qualify to receive a biological medication. Depending on where an individual lives, he or she may or may not be eligible to receive newer treatments. View the details for each province:

special access

If a treatment has been decided but you have a prerequisite and no contraindications to this prerequisite- and your dermatologist (or rheumatologist) and you prefer to move ahead without having to try the prerequisite medication.  In some provinces a special fund exists that may cover the cost for your preferred medication. Contact your provincial or territorial health department websites as outlined in this table, where you can also obtain more information and up to date status on public coverage. You can also obtain more information and up to date status on public coverageat these government websites (provincial and territories).

public coverage

 If not successful, see the “Other Options for Access” section